Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, Milan, Italy.
Int J Biochem Cell Biol. 2010 Feb;42(2):210-3. doi: 10.1016/j.biocel.2009.11.015. Epub 2009 Nov 22.
Cellular FLICE-inhibitory protein (c-FLIP) is a catalytically inactive procaspase-8/10 homologue that associates with the signalling complex downstream of death-receptors negatively interfering with apoptotic signalling. Three c-FLIP splice variants have been identified: c-FLIP(L), c-FLIP(S) and c-FLIP(R), with all three functioning as apoptosis inhibitors involved in modulation of caspase-8/10 activity in both physiologic and pathologic contexts. Furthermore, a cell-type specific pro-apoptotic role, depending on caspase-8 to c-FLIP(L) ratio, has also been described for the long isoform. The present review summarizes recent findings concerning c-FLIP proteins' function and regulation, with a main focus on the c-FLIP(L) deregulated expression in cancer. The role of c-FLIP(L) as anti-apoptotic pro-survival factor in tumors and the potential utility of this molecule as a possible alternative therapeutic target are discussed.
细胞型 Fas 相关死亡区域蛋白(c-FLIP)是一种无酶活性的胱天蛋白酶-8/10 同系物,它与死亡受体下游的信号复合物结合,负向干扰凋亡信号。已经鉴定出三种 c-FLIP 剪接变体:c-FLIP(L)、c-FLIP(S)和 c-FLIP(R),这三种变体都作为凋亡抑制剂,参与生理和病理环境中胱天蛋白酶-8/10 活性的调节。此外,长型异构体还具有依赖于胱天蛋白酶-8 与 c-FLIP(L) 比值的细胞类型特异性促凋亡作用。本综述总结了有关 c-FLIP 蛋白功能和调节的最新发现,主要关注癌症中 c-FLIP(L) 的失调表达。讨论了 c-FLIP(L) 作为肿瘤中抗凋亡生存因子的作用,以及该分子作为潜在替代治疗靶点的可能用途。